Hollsteen
← KLA

D&A

Flow – sum over the period · $M

QuartersFiscal years

$MD&A · Q1 FY2016: $20.0M · 10-Q 0000319201-15-000060 filed Oct 22, 2015D&A · Q2 FY2016: $17.0M · derived · 10-Q 0000319201-17-000006 filed Jan 27, 2017D&A · Q3 FY2016: $16.0M · derived · 10-Q 0000319201-17-000017 filed Apr 28, 2017D&A · Q4 FY2016: $15.0M · derived · 10-K 0000319201-17-000034 filed Aug 4, 2017D&A · Q1 FY2017: $14.0M · 10-Q 0000319201-16-000104 filed Oct 20, 2016D&A · Q2 FY2017: $15.0M · derived · 10-Q 0000319201-18-000008 filed Jan 26, 2018D&A · Q3 FY2017: $14.0M · derived · 10-Q 0000319201-18-000021 filed Apr 27, 2018D&A · Q4 FY2017: $14.0M · derived · 10-K 0000319201-18-000045 filed Aug 6, 2018D&A · Q1 FY2018: $15.0M · 10-Q 0000319201-17-000045 filed Oct 27, 2017D&A · Q2 FY2018: $16.0M · derived · 10-Q 0000319201-19-000009 filed Jan 29, 2019D&A · Q3 FY2018: $16.0M · derived · 10-Q 0000319201-19-000018 filed May 8, 2019D&A · Q4 FY2018: $15.0M · derived · 10-K 0000319201-19-000031 filed Aug 16, 2019D&A · Q1 FY2019: $16.0M · 10-Q 0000319201-18-000055 filed Oct 31, 2018D&A · Q2 FY2019: $16.0M · derived · 10-Q 0000319201-20-000008 filed Feb 5, 2020D&A · Q3 FY2019: $73.0M · derived · 10-Q 0000319201-20-000026 filed May 6, 2020D&A · Q4 FY2019: $128M · derived · 10-K 0000319201-20-000047 filed Aug 10, 2020D&A · Q1 FY2020: $99.0M · 10-Q 0000319201-19-000039 filed Oct 31, 2019D&A · Q2 FY2020: $89.0M · derived · 10-Q 0000319201-21-000008 filed Feb 4, 2021D&A · Q3 FY2020: $82.0M · derived · 10-Q 0000319201-21-000017 filed Apr 30, 2021D&A · Q4 FY2020: $79.0M · derived · 10-K 0000319201-21-000029 filed Aug 6, 2021D&A · Q1 FY2021: $80.0M · 10-Q 0000319201-20-000057 filed Oct 30, 2020D&A · Q2 FY2021: $84.0M · derived · 10-Q 0000319201-22-000006 filed Jan 28, 2022D&A · Q3 FY2021: $84.0M · derived · 10-Q 0000319201-22-000012 filed Apr 29, 2022D&A · Q4 FY2021: $85.0M · derived · 10-K 0000319201-22-000023 filed Aug 5, 2022D&A · Q1 FY2022: $85.0M · 10-Q 0000319201-21-000037 filed Oct 28, 2021D&A · Q2 FY2022: $86.0M · derived · 10-Q 0000319201-23-000010 filed Jan 27, 2023D&A · Q3 FY2022: $92.0M · derived · 10-Q 0000319201-23-000020 filed Apr 28, 2023D&A · Q4 FY2022: $101M · derived · 10-K 0000319201-23-000031 filed Aug 4, 2023D&A · Q1 FY2023: $102M · 10-Q 0001628280-22-027311 filed Oct 28, 2022D&A · Q2 FY2023: $104M · derived · 10-Q 0000319201-24-000006 filed Jan 26, 2024D&A · Q3 FY2023: $105M · derived · 10-Q 0000319201-24-000012 filed Apr 26, 2024D&A · Q4 FY2023: $105M · derived · 10-K 0000319201-24-000021 filed Aug 5, 2024D&A · Q1 FY2024: $102M · 10-Q 0000319201-23-000039 filed Oct 27, 2023D&A · Q2 FY2024: $99.0M · derived · 10-Q 0000319201-25-000006 filed Jan 31, 2025D&A · Q3 FY2024: $99.0M · derived · 10-Q 0000319201-25-000012 filed May 1, 2025D&A · Q4 FY2024: $101M · derived · 10-K 0000319201-25-000024 filed Aug 8, 2025D&A · Q1 FY2025: $96.0M · 10-Q 0000319201-24-000027 filed Oct 31, 2024D&A · Q2 FY2025: $104M · derived · 10-Q 0000319201-26-000008 filed Jan 30, 2026D&A · Q3 FY2025: $98.0M · derived · 10-Q 0000319201-26-000016 filed Apr 30, 2026D&A · Q4 FY2025: $96.0M · derived · 10-K 0000319201-26-000027 filed Aug 6, 2026D&A · Q1 FY2026: $97.0M · 10-Q 0000319201-25-000034 filed Oct 31, 2025D&A · Q2 FY2026: $99.0M · derived · 10-Q 0000319201-26-000008 filed Jan 30, 2026D&A · Q3 FY2026: $99.0M · derived · 10-Q 0000319201-26-000016 filed Apr 30, 2026D&A · Q4 FY2026: $99.0M · derived · 10-K 0000319201-26-000027 filed Aug 6, 202698.6a19.7127.9aQ1 FY2016Q4 FY2026Q3 FY2021
$MD&A · Q1 FY2025: $96.0M · 10-Q 0000319201-24-000027 filed Oct 31, 2024D&A · Q2 FY2025: $104M · derived · 10-Q 0000319201-26-000008 filed Jan 30, 2026D&A · Q3 FY2025: $98.0M · derived · 10-Q 0000319201-26-000016 filed Apr 30, 2026D&A · Q4 FY2025: $96.0M · derived · 10-K 0000319201-26-000027 filed Aug 6, 2026D&A · Q1 FY2026: $97.0M · 10-Q 0000319201-25-000034 filed Oct 31, 2025D&A · Q2 FY2026: $99.0M · derived · 10-Q 0000319201-26-000008 filed Jan 30, 2026D&A · Q3 FY2026: $99.0M · derived · 10-Q 0000319201-26-000016 filed Apr 30, 2026D&A · Q4 FY2026: $99.0M · derived · 10-K 0000319201-26-000027 filed Aug 6, 202698.6a95.8Q1 FY2025Q4 FY2026Q1 FY2026
Q4 FY2026
98.6a$M
derived
All values (44)
PeriodValue ($M)Status
Q4 FY202698.6derived
Q3 FY202699.1derived
Q2 FY202699.3derived
Q1 FY202697.0reported
Q4 FY202596.3derived
Q3 FY202598.1derived
Q2 FY2025103.9derived
Q1 FY202595.8reported
Q4 FY2024101.0derived
Q3 FY202499.3derived
Q2 FY202499.1derived
Q1 FY2024102.4reported
Q4 FY2023104.8derived
Q3 FY2023104.9derived
Q2 FY2023103.5derived
Q1 FY2023101.9reported
Q4 FY2022100.8derived
Q3 FY202292.1derived
Q2 FY202285.5derived
Q1 FY202284.8reported
Q4 FY202184.6derived
Q3 FY202184.4derived
Q2 FY202184.3derived
Q1 FY202180.1reported
Q4 FY202078.9derived
Q3 FY202082.0derived
Q2 FY202088.5derived
Q1 FY202098.6reported
Q4 FY2019127.9derived
Q3 FY201973.4derived
Q2 FY201915.8derived
Q1 FY201916.1reported
Q4 FY201815.0derived
Q3 FY201816.3derived
Q2 FY201816.1derived
Q1 FY201815.3reported
Q4 FY201714.3derived
Q3 FY201714.2derived
Q2 FY201714.9derived
Q1 FY201714.4reported
Q4 FY201614.9derived
Q3 FY201615.8derived
Q2 FY201616.5derived
Q1 FY201619.7reported

CSV with all sources · Technical ID: dna

More metrics for KLA

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Gross profit by segment

Sources & calculation
Value
$99.0M (derived)
Period
Q4 FY2026, ended Jun 30, 2026 · quarterly value (3 months, not cumulative)
Calculation
Q4 = fiscal year − 9 months cumulative = 394M − 295M = $99.0M (FY value from 10-K 0000319201-26-000027; 9-month value from the Q3-10-Q)
Source
10-K, filed Aug 6, 2026 · 0000319201-26-000027
Location
us-gaap:DepreciationDepletionAndAmortization
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$99.0MAug 6, 202610-K 0000319201-26-000027derived · confidence 1. · current